Loading data
KLACNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 13.58 bn USD | 12.16 bn USD | 9.81 bn USD | 10.5 bn USD | 9.21 bn USD |
| Cost of revenue | 5.26 bn USD | 4.75 bn USD | 3.93 bn USD | 4.22 bn USD | 3.59 bn USD |
| Research and development expense | 1.53 bn USD | 1.36 bn USD | 1.28 bn USD | 1.3 bn USD | 1.11 bn USD |
| Selling, general and administrative expense | 1.13 bn USD | 1.03 bn USD | 969.51 m USD | 986.33 m USD | 860.01 m USD |
| Interest expense | — | — | — | 296.94 m USD | 160.34 m USD |
| Profit before tax | 5.61 bn USD | 4.64 bn USD | 3.19 bn USD | 3.79 bn USD | 3.49 bn USD |
| Income tax expense | 775.15 m USD | 582.81 m USD | 428.14 m USD | 401.84 m USD | 167.18 m USD |
| Net income (reported basis) | 4.83 bn USD | 4.06 bn USD | 2.76 bn USD | 3.39 bn USD | 3.32 bn USD |
| Net income attributable to common shareholders | — | — | — | — | 3.32 bn USD |
| Basic earnings per share | 3.68 USD/share | 3.05 USD/share | 2.04 USD/share | 24.28 USD/share | 22.07 USD/share |
| Diluted earnings per share | 3.66 USD/share | 3.04 USD/share | 2.03 USD/share | 24.15 USD/share | 21.92 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.